Navigation Links
A New Test Developed to Identify Suspected Bowel Cancer Patients

Researchers have announced a new test to identify patients who develop bowel cancer as they have a particular gene that could be at fault is unveiled today//.

An Edinburgh University team conducted the test study, and they presented their report in the New England Journal of Medicine. They explained that the tests would help to make certain that these patients could then get the best treatment and will help identify relatives with the same mutation who might have a great increase in the risk of cancer.

The researchers said that around 20,000 people in the general population are thought to have this exacting class of genetic defect, which is associated with a very high risk of cancer. They explained that the biggest challenge was to identify these people, so as to start preventive measures before the disease kicks in or very early in its stage, so as to have a much higher rates of success in controlling it. It was explained that this study that has been reported was a significant step towards this goal.

The researchers explained that the team had developed the test in a long-term study that involved 870 patients, primarily focusing on the faults in three genes, MLH1, MSH2 and MSH6, which are considered responsible for proteins that help to prevent the DNA damage that are linked with tumour development.

The findings of the team showed that 38, about4% of the patients had faulty genes, almost twice as many as suggested by previous estimates. Prof Malcolm Dunlop, one of the researcher said, 'In the long term, we hope the results of this study will help identify all bowel cancer patients who carry one of these gene faults and then offer tests to their relatives who have not yet developed cancer, so that we can prevent the development of cancer.'

Prof Alex Markham, the chief executive of Cancer Research UK, said: 'These are very valuable findings that will help scientists better understand the process of bowel cancer development, particularly in people who are diagnosed at a young age.'


'"/>




Related medicine news :

1. Scientists Developed Map For Brain Molecular Communities
2. Scientists Developed Cheap Way To Assess Sleep
3. Diabetic Friendly Egg Developed In India
4. Three In One Ultrasound Probe For 3-D Imaging Of Heart And Tissue Destruction Developed
5. Cervical Cancer Vaccine To Be Developed In India
6. Anti-Microbial Coating For Use Over Biomedical Devices Developed
7. Cure for Osteoarthritis To Be Developed
8. Mice With Human Thought Processes Could Be Developed In The Future
9. Viagra Pill For Women To Be Developed
10. Male Contraceptive Pill Being Developed By Berlin Pharmaceutical
11. New Fertility Predictor Test Developed
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/3/2016)... ... ... Each year, about 800,000 people suffer from cerebral vascular accidents, or strokes. ... for one death every four minutes. Many people who survive a stroke are ... a video series called “Your Brain,” in conjunction with its medical journal “Balance,” in ...
(Date:5/3/2016)... Toronto, ON (PRWEB) , ... May 03, 2016 ... ... been recognized as one of Canada’s top Information and Communication Technology (ICT) companies ... top Canadian and Multinational ICT companies operating in Canada, as ranked by revenue. ...
(Date:5/3/2016)... (PRWEB) , ... May 03, 2016 , ... Branches, Inc. ... its Grow & Climb children and youth programs in South Miami. Macy’s is a ... , The Grow Program provides afterschool tutoring, mentoring, enrichment and academic support to ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... healthcare organizations, especially medium and small physician practices, to better grasp and implement ... step-by-step approach that guides practices on a well-defined, expert-created path to compliance. HIPAA ...
(Date:5/2/2016)... Denver, CO (PRWEB) , ... May 02, 2016 , ... ... will serve as the keynote speaker for five events throughout the month of May. ... for a number of national news outlets. He also frequently appears on the Science ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... Glycotope GmbH, a clinical-stage immuno-oncology ... appointment of Dr. Alfredo Zurlo as Chief ... with many years clinical experience and a proven track ... role was at Mologen AG where he was Chief ... Dr. Zurlo held various positions at F Hoffmann La ...
(Date:4/28/2016)... , April 28, 2016  Marking its ... accessible breast and ovarian cancer risk test, ... analyzing 30 genes that highly impact the most ... Available today, the Color Test analyzes hereditary cancer ... stomach, and uterine cancers. The Color Test is ...
(Date:4/28/2016)... Dr. Vivek Ahuja , ... Ste phen Schmidt Join the ... software solutions for life sciences, today announced key new leaders have ... insight to a growing business.  This will bolster the company,s safety ... joined ArisGlobal in the position of Vice President - Safety. ...
Breaking Medicine Technology: